Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AB Dynamix appears to have been a small private consulting company serving pharmaceutical, biotechnology, and medical device clients rather than a drug developer. Public references describe the business as providing customized quality management systems, regulatory strategies, and supply-chain support for healthcare product companies. The entity most consistently identified is AB Dynamix LLC, associated with Alpharetta, Georgia, and led by Aaron Bartlone prior to his move to Cybin. Available evidence does not indicate an internal therapeutic pipeline, proprietary drug platform, or clinical-stage assets. Corporate registry data suggest the company is no longer active.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AB Dynamix.